These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31810814)

  • 1. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease.
    Vu M; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Kettunen R; Hartikainen S; Tolppanen AM
    Int J Cardiol; 2020 Feb; 300():221-225. PubMed ID: 31810814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
    Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
    J Alzheimers Dis; 2018; 66(1):387-395. PubMed ID: 30282366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the use of diabetes drugs among community-dwelling people with Alzheimer's disease.
    López-Rubio C; Koponen M; Lampela P; Taipale H; Tanskanen A; Bell JS; Tolppanen AM; Hartikainen S
    BMC Geriatr; 2021 Dec; 21(1):701. PubMed ID: 34911481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
    Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
    Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
    Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
    BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
    Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.
    Järvinen H; Tolppanen AM; Hartikainen S
    BMC Geriatr; 2023 Apr; 23(1):227. PubMed ID: 37038120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
    Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
    J Alzheimers Dis; 2018; 64(2):437-445. PubMed ID: 29914029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
    Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
    Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
    PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease.
    Juntunen H; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Tiihonen M
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1149-1158. PubMed ID: 28577224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort.
    Tolppanen AM; Kettunen R; Ahonen R; Soininen H; Hartikainen S
    Int J Cardiol; 2013 Dec; 170(2):195-201. PubMed ID: 24200309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
    Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
    Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
    Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
    Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study.
    Tolppanen AM; Tiihonen M; Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tiihonen J; Hartikainen S
    Drugs Aging; 2018 Nov; 35(11):985-992. PubMed ID: 30317535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.
    Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
    BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.